Poop transplants improved Parkinson's motor scores by ~10 points in a meta-analysis of 220 patients

Key Findings

🧪 Microplastics May Speed Up Alzheimer's-Like Pathology in Mice — Via a Taurine Deficit

In genetically predisposed (5XFAD) mice, chronic oral exposure to 2-µm plastic microparticles was associated with accelerated cognitive decline, more amyloid-beta deposits, and greater synaptic loss — all running through the gut-brain axis.

• Microplastics accumulated in the gut, disrupted the intestinal barrier, and selectively expanded a bacterium called Bilophila — which depletes taurine (an amino acid with neuroprotective roles).
• A systemic taurine deficit preceded and correlated with worsened brain pathology. Restoring taurine levels improved microglial function and rescued memory deficits in the treated mice.
• In humans: taurine levels were significantly lower in Alzheimer's patients vs. cognitively normal controls in the ADNI dataset, and inversely correlated with cognitive decline.
• Antibiotic-mediated microbiome wipeout and fecal transplant experiments confirmed the neurotoxic phenotype was microbiota-dependent.

🔬 Short-Chain Fatty Acids Cut Epilepsy Progression 3-Fold in Drug-Resistant Mouse Model

In mice with drug-resistant epilepsy (induced by status epilepticus), supplementing with a mixture of acetate, propionate, and butyrate — short-chain fatty acids (SCFAs) produced naturally by gut bacteria — reduced disease progression significantly over 70 days of EEG monitoring.

• SCFA supplementation reduced the overall progression index 3-fold, and fewer mice developed a progressive seizure phenotype.
• Daily seizure frequency wasn't significantly changed, but seizure clustering decreased — suggesting a disease-modifying rather than purely seizure-suppressing effect.
• Cognitive deficits improved, and both hippocampal and intestinal tissue damage were partially restored.
• Brain SCFA levels were partially normalized in treated mice. Human epilepsy brain tissue analysis also showed patterns consistent with gut-brain axis dysfunction.

🧠 Gut Bacteria Linked to Anxiety and Depression in IBD — Even in Remission

A systematic review of 10 studies (6 prospective cohorts + 4 randomized trials) covering 1,040 IBD patients found consistent links between gut microbiome composition and psychological symptoms.

• Anxiety and depression were associated with lower microbial diversity and higher levels of pro-inflammatory bacteria — and these associations held even in patients whose IBD was in remission, suggesting the link isn't fully explained by active gut inflammation.
• Depletion of bacteria that produce short-chain fatty acids (like butyrate) was a recurring pattern in patients with worse psychological symptoms.
• Randomized trials of probiotics and fecal microbiota transplantation showed reductions in anxiety and depression scores alongside changes in microbial composition.
• Psychological interventions also appeared to shift gut microbial profiles, pointing to a potentially bidirectional relationship.

🌿 A Plant Compound (Ineupatorolide B) May Reduce Depression-Like Behavior in Mice — But Only If the Vagus Nerve Is Intact

In mice exposed to chronic social defeat stress (a standard depression model), a compound called ineupatorolide B (InB) — extracted from plants, with known anti-inflammatory properties — reversed several depression-related changes.

• InB reversed elevated IL-6 and TNF-α (inflammatory markers), splenomegaly (spleen enlargement), and reduced expression of PSD-95 and BDNF (proteins important for brain plasticity) in the prefrontal cortex.
• 16S rRNA sequencing showed CSDS disrupted gut microbial diversity; InB largely normalized this and restored levels of depression-associated short-chain fatty acids (isobutyric and valeric acid).
• Critically: when the vagus nerve was surgically cut (subdiaphragmatic vagotomy), InB's antidepressant-like, anti-inflammatory, and synaptic effects were all abolished — suggesting the gut-to-brain signal travels via the vagus nerve.

🔍 A New Framework Proposes to Fix How Gut-Brain Research Establishes Causality

A perspective paper argues that gut-brain axis research is stuck in a methodological loop: most studies are cross-sectional, use limited sequencing techniques (16S rRNA), and can't separate cause from effect in a bidirectional system.

• The proposed "Causality Funnel" framework prioritizes human-first discovery using Mendelian randomization (a method that uses genetic variants as natural experiments to test causal hypotheses), followed by multi-omics to identify mechanisms, then validation in germ-free animal models.
• The framework is designed to be resource-efficient: expensive mechanistic experiments are only run on hypotheses that already have strong human-level support.
• Pediatric epilepsy and neurodevelopmental trajectories are offered as concrete test cases for this approach.

💊 Gut Leakiness Linked to Brain Health Differently in Men vs. Women (827 Middle-Aged Adults)

In 827 healthy middle-aged adults (median age 52; 427 male) from the Barcelona Brain Health Initiative, researchers measured intestinal permeability (IP) biomarkers — including LBP (lipopolysaccharide-binding protein) and zonulin — alongside brain MRI, neurofilament light chain (NfL, a marker of nerve damage), and neuropsychological data.

• In women, higher IP biomarkers clustered with age, hypertension, and high cholesterol — and this cluster was linked to lower cortical and white-matter brain volumes and higher plasma NfL (all p < 0.05).
• In men, IP biomarkers combined with high alcohol consumption were associated with reduced hippocampal and cortical volumes and higher NfL.
• Only in women were these IP-related patterns associated with increased odds of neurological disease diagnosis over 4 years (OR: 2.3, 95% CI: 1.5–3.6).
• When individual IP biomarkers were tested alone (without the clustering approach), associations with brain health were minor after adjusting for lifestyle factors.